Your Concept to Potential Therapeutic
Our Process Development Services will help you take the next step by building clinical processes that are ready to scale and specific to your concept—or product—needs. RoosterBio’s solutions enable custom manufacturing processes that align with regulatory guidance, are scalable from product development to clinical manufacturing, and are designed to help you rapidly progress from where you are today to tomorrow’s potential therapeutic.Process Development Services
Advanced therapy programs are complex arrays of upstream and downstream processes that must reliably work together to produce consistent products worthy of clinical use. Our hMSC Analytical Services and Exosome Analytical Service offerings utilize our industry-leading hMSC and exosome knowledge to give you the information you need pre-process, in-process, and post-process to ensure your products maintain the critical quality attributes you care about.
Overcome Challenges for Advanced Therapies
Whether you use human Mesenchymal Stem/Stromal Cells (hMSCs) as your finished therapeutic or as a process step along the way, knowing your cells is paramount to defining your product. Regardless of tissue type or donor source, our hMSC Analytical Services provide the data you need to assess your hMSCs.
Exosomes / Extracellular Vesicles (EVs) are becoming the next frontier of biologics and advanced therapies. Despite their clinical potential, traditional analytical strategies fail to capture the heterogeneity and engineered complexity encountered during procurement or production. We have developed an extensive panel of analytical methods that address these challenges and can characterize your samples at both the population and single-particle level.Exosome Analytical Services
Want to Further Maximize Your Therapeutic Program?
We’re happy to share our expertise.